Skip to main content
Biomolecules & Therapeutics logoLink to Biomolecules & Therapeutics
. 2022 Jul 5;31(1):139. doi: 10.4062/biomolther.2022.005

Erratum to "Synthetic Homoisoflavane Derivatives of Cremastranone Suppress Growth of Colorectal Cancer Cells through Cell Cycle Arrest and Induction of Apoptosis" [Biomol. Ther. 30 (2022) 576-584]

Ha-Eun Shin 1,, Seul Lee 2,, Yeram Choi 1, Sangkyu Park 3, Sangil Kwon 2, Jun-Kyu Choi 3, Seung-Yong Seo 2,*, Younghee Lee 1,3,*
PMCID: PMC9810447  PMID: 36535633

The authors request to correct the structure of SH-19017 in Fig. 1B on page 579. The authors synthesized a variety of creamstranone derivatives and unintentionally presented the structure of another compound. As SH-19017 had no cytotoxic effect as shown in Supplementary Fig. 2, this error does not affect the conclusion of the article. However, the authors apologize for this accidental error and inconvenience.

Fig. 1.

Fig. 1

Structure of cremastranone and homoisoflavane derivatives. (A) Natural product cremastranone and synthetic homoisoflavane SH-17059, (B) A-ring modification of SH-17059, and (C) B-ring modification of SH-17059.


Articles from Biomolecules & Therapeutics are provided here courtesy of Korean Society of Applied Pharmacology

RESOURCES